Riferimento farmaci
Palovarotene
Palovarotene is a medicine in the class miscellaneous. It is used for heterotopic ossification.
- Classe del farmaco: Miscellaneous
- Indicato per: heterotopic ossification
Ultimo aggiornamento Fonti: US FDA label
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
In breve
- Classe del farmaco
- Miscellaneous
- Forme farmaceutiche comuni
- capsula
- Interazioni note
- 47 (Controindicata: 2 · Maggiore: 34 · Moderata: 7 · Minore: 4)
- Nomi commerciali
- 1
- Paesi e mercati
- 1
Per cosa si usa
Come agisce
Retinoic acid receptor agonist with selectivity for the gamma subtype (RARγ). Binding to RARγ decreases BMP/ALK2 downstream signaling by inhibiting SMAD1/5/8 phosphorylation, which reduces endochondral bone formation.
Dose abituale nell'adulto (sintesi del foglio illustrativo)
FOP, adults and patients 14 years and older, daily dose: 5 mg orally once daily with food. Stop daily dosing when flare-up dosing begins.
Gravidanza e allattamento
- Gravidanza
- Unsafe Contraindicated in pregnancy; can cause fetal harm. Retinoid-type malformations were seen in rats. No human data are available.
- Allattamento
- Unsafe No data on presence in milk. Breastfeeding is not recommended during treatment and for at least 1 month after the final dose.
Effetti indesiderati segnalati
- Dry skin
- Dry lips
- Arthralgia
- Pruritus
- Pain in extremity
- Rash
Avvertenze in evidenza
- Embryo-fetal toxicity: contraindicated in pregnancy and may cause fetal harm. Give only if conditions for pregnancy prevention are met.
Controindicazioni
- Pregnancy.
- History of allergy or hypersensitivity to retinoids or any component of SOHONOS.
Chi deve prestare attenzione
- Embryo-fetal toxicity: verify non-pregnancy before, during and 1 month after treatment; use effective contraception; do not donate blood during therapy and for 1 week after.
- Irreversible premature epiphyseal closure in growing children; assess baseline skeletal maturity and monitor every 6 to 12 months.
- Mucocutaneous reactions occurred in 98% of patients and may increase the risk of skin and soft tissue infections; photosensitivity may occur.
Informare il farmacista o il medico di gravidanza o allattamento, malattie renali o epatiche, allergie e di ogni altro farmaco o integratore assunto.
Interazioni principali (47)
- Acitretin + Palovarotene Contraindicated
- Isotretinoin + Palovarotene Contraindicated
- Amiodarone + Palovarotene Major
- Amobarbital + Palovarotene Major
- Apalutamide + Palovarotene Major
- Aprepitant + Palovarotene Major
- Carbamazepine + Palovarotene Major
- Chloramphenicol + Palovarotene Major
- Clarithromycin + Palovarotene Major
- Crizotinib + Palovarotene Major
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per aprire la monografia completa di Palovarotene: dosi, gravidanza e allattamento, effetti indesiderati, avvertenze e tutte le interazioni.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Paediatric dosing
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
- Food interactions
Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.
Domande frequenti
What is Palovarotene used for?
Palovarotene is a medicine in the class miscellaneous. It is used for Heterotopic ossification.
What side effects have been reported with Palovarotene?
Dry skin, Dry lips, Arthralgia, Pruritus, Pain in extremity, Rash. Serious warning: Embryo-fetal toxicity: contraindicated in pregnancy and may cause fetal harm.
Can Palovarotene be taken in pregnancy or while breastfeeding?
Pregnancy: Unsafe. Contraindicated in pregnancy; can cause fetal harm. Retinoid-type malformations were seen in rats. No human data are available. Breastfeeding: Unsafe. No data on presence in milk. Breastfeeding is not recommended during treatment and for at least 1 month after the final dose.
What does Palovarotene interact with?
MediHelp lists 47 known interactions for Palovarotene. Contraindicated: 2 · Major: 34 · Moderate: 7 · Minor: 4. The most serious include Acitretin, Isotretinoin, Amiodarone.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
